RespireRx Pharmaceuticals Inc (RSPI): K-G, That's shown as a preclinical prog...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	87
Posts	33307
Boards Moderated	87
Alias Born	03/22/2005

gfp927z

Re: K-G post# 34560

Saturday, 10/30/2010 4:05:50 PM

Saturday, October 30, 2010 4:05:50 PM

K-G, That's shown as a preclinical program targeting AD (link below). Servier still owns a few compounds that came out of the former collaboration with Cortex. Servier had the Euro rights to neurodegenerative indications, but that partnership was ended early by Cortex -

http://www.cortexpharm.com/prodpipe/index.html

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent RSPI News

Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 12:45:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 12:30:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:01:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:03:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM